Gut 157 Gut-barrier focus gut barrier integrity studied in preclinical mucosal models $99.99 What is Stack 157
Yes, semaglutide is itself a peptide (a GLP-1 receptor agonist)
The product stimulates appetite, which improves feed intake and ultimately enhances growth, weight gain and production
Pedrosa ML, Furtado MH, Ferreira MCF, Carneiro MM
FDA's stated reasons: Immunogenicity risk Could trigger immune reactions Impurities Compounded versions may be contaminated Lack of characterization Don't fully understand the molecules No human safety data Haven't been properly tested Reported adverse events Some have documented side effects The DOJ Prosecution: $1.79 Million Forfeiture In a landmark case, the Department of Justice prosecuted Tailor Made Compounding LLC for distributing unapproved peptides including BPC-157
This is the number we'll work with, as research doses are almost always measured in mcg